$RSLS
ReShape Lifesciences Inc.

2024 Q3 Form 10-Q Financial Statement

#000155837024012246 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $2.292M $1.965M
YoY Change 6.36% -12.82%
Cost Of Revenue $853.0K $831.0K
YoY Change -1.61% -21.6%
Gross Profit $1.439M $1.134M
YoY Change 11.72% -5.03%
Gross Profit Margin 62.78% 57.71%
Selling, General & Admin $719.0K $670.0K
YoY Change -59.85% -69.22%
% of Gross Profit 49.97% 59.08%
Research & Development $399.0K $399.0K
YoY Change -26.38% -31.33%
% of Gross Profit 27.73% 35.19%
Depreciation & Amortization $6.000K
YoY Change -87.76%
% of Gross Profit 0.53%
Operating Expenses $3.200M $3.188M
YoY Change -38.08% -38.34%
Operating Profit -$1.761M -$2.054M
YoY Change -54.61% -48.34%
Interest Expense $4.000K
YoY Change -55.56%
% of Operating Profit
Other Income/Expense, Net $109.0K $59.00K
YoY Change 883.33%
Pretax Income -$1.575M -$1.580M
YoY Change -55.4% -54.71%
Income Tax $6.000K $15.00K
% Of Pretax Income
Net Earnings -$1.581M -$1.595M
YoY Change -55.26% -54.34%
Net Earnings / Revenue -68.98% -81.17%
Basic Earnings Per Share -$3.11 -$0.06
Diluted Earnings Per Share -$3.11 -$0.06
COMMON SHARES
Basic Shares Outstanding 29.39M 23.46M
Diluted Shares Outstanding 508.9K 25.22M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.053M
YoY Change -76.94%
Cash & Equivalents $743.0K $1.053M
Short-Term Investments
Other Short-Term Assets $51.00K $55.00K
YoY Change -45.74% -50.89%
Inventory $2.934M $3.246M
Prepaid Expenses
Receivables $1.300M $1.400M
Other Receivables $15.00K
Total Short-Term Assets $5.338M $6.087M
YoY Change -27.86% -42.27%
LONG-TERM ASSETS
Property, Plant & Equipment $43.00K $48.00K
YoY Change -38.57% -92.72%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $29.00K $29.00K
YoY Change 0.0% -49.12%
Total Long-Term Assets $277.0K $306.0K
YoY Change -35.28% -76.61%
TOTAL ASSETS
Total Short-Term Assets $5.338M $6.087M
Total Long-Term Assets $277.0K $306.0K
Total Assets $5.615M $6.393M
YoY Change -28.26% -46.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.105M $1.030M
YoY Change 43.98% -35.67%
Accrued Expenses $1.643M $1.895M
YoY Change -39.9% -25.01%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.025M $3.201M
YoY Change -9.94% -27.32%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $157.0K
YoY Change -77.89%
Total Long-Term Liabilities $157.0K
YoY Change -77.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.025M $3.201M
Total Long-Term Liabilities $157.0K
Total Liabilities $4.128M $3.358M
YoY Change -12.98% -34.34%
SHAREHOLDERS EQUITY
Retained Earnings -$640.9M -$639.4M
YoY Change 1.11% 1.43%
Common Stock $29.00K
YoY Change 866.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.487M $3.035M
YoY Change
Total Liabilities & Shareholders Equity $5.615M $6.393M
YoY Change -28.26% -46.06%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$1.581M -$1.595M
YoY Change -55.26% -54.34%
Depreciation, Depletion And Amortization $6.000K
YoY Change -87.76%
Cash From Operating Activities -$1.357M
YoY Change -79.63%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 24.00K
YoY Change -98.93%
NET CHANGE
Cash From Operating Activities -1.357M
Cash From Investing Activities 0.000
Cash From Financing Activities 24.00K
Net Change In Cash -1.333M
YoY Change -69.81%
FREE CASH FLOW
Cash From Operating Activities -$1.357M
Capital Expenditures $0.00
Free Cash Flow -$1.357M
YoY Change -79.74%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001427570
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23457047
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29387120
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-37897
dei Entity Registrant Name
EntityRegistrantName
RESHAPE LIFESCIENCES INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1828101
dei Entity Address Address Line1
EntityAddressAddressLine1
18 Technology Dr, Suite 110
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92618
dei City Area Code
CityAreaCode
949
dei Local Phone Number
LocalPhoneNumber
429-6680
dei Security12b Title
Security12bTitle
Common stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
RSLS
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29387152
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1053000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4459000
CY2024Q2 us-gaap Restricted Cash
RestrictedCash
100000
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
100000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
636000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
804000
CY2024Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
1382000
CY2023Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
1659000
CY2024Q2 us-gaap Inventory Net
InventoryNet
3246000
CY2023Q4 us-gaap Inventory Net
InventoryNet
3741000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
306000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
337000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
6087000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
10296000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
60000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
202000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
250000
CY2024Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
27000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
28000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
29000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
29000
CY2024Q2 us-gaap Assets
Assets
6393000
CY2023Q4 us-gaap Assets
Assets
10663000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1030000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1689000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1895000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1814000
CY2024Q2 rsls Warrant Liability Current
WarrantLiabilityCurrent
163000
CY2023Q4 rsls Warrant Liability Current
WarrantLiabilityCurrent
163000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
113000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
111000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3201000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3777000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
103000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
151000
CY2024Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
54000
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
72000
CY2024Q2 us-gaap Liabilities
Liabilities
3358000
CY2023Q4 us-gaap Liabilities
Liabilities
4000000
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29387120
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23457047
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
29000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
23000
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
642457000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
642302000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-639362000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-635574000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-89000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-88000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
3035000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6663000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6393000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10663000
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1965000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2254000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3909000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4541000
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
831000
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1060000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1610000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2123000
CY2024Q2 us-gaap Gross Profit
GrossProfit
1134000
CY2023Q2 us-gaap Gross Profit
GrossProfit
1194000
us-gaap Gross Profit
GrossProfit
2299000
us-gaap Gross Profit
GrossProfit
2418000
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
670000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2177000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1689000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4359000
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2119000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2445000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3991000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6667000
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
399000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
581000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
883000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1033000
CY2023Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
33000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
33000
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
3188000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
5170000
us-gaap Operating Expenses
OperatingExpenses
6563000
us-gaap Operating Expenses
OperatingExpenses
12026000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2054000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3976000
us-gaap Operating Income Loss
OperatingIncomeLoss
-4264000
us-gaap Operating Income Loss
OperatingIncomeLoss
-9608000
CY2024Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
4000
CY2023Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
9000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
13000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
4000
CY2024Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2000
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-472000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-18000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3438000
CY2024Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
429000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
429000
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-16000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-40000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
21000
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
59000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
84000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1580000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3489000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3760000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6137000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1595000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3493000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3788000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6155000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.08
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.48
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.48
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25222443
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25222443
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3249259
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3249259
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24339785
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24339785
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2482957
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2482957
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1595000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3493000
us-gaap Net Income Loss
NetIncomeLoss
-3788000
us-gaap Net Income Loss
NetIncomeLoss
-6155000
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
7000
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-7000
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
7000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-7000
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1588000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3495000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3789000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6162000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
4534000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1595000
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
7000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
65000
CY2024Q2 rsls Stock And Warrants Issued During Period Value Institutional Exercise Of Warrants
StockAndWarrantsIssuedDuringPeriodValueInstitutionalExerciseOfWarrants
24000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
3035000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6663000
us-gaap Net Income Loss
NetIncomeLoss
-3788000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
137000
rsls Stock And Warrants Issued During Period Value Institutional Exercise Of Warrants
StockAndWarrantsIssuedDuringPeriodValueInstitutionalExerciseOfWarrants
24000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
3035000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
7758000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3493000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
217000
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
894000
CY2023Q2 rsls Adjustments To Additional Paid In Capital Stock Offering Costs
AdjustmentsToAdditionalPaidInCapitalStockOfferingCosts
-207000
CY2023Q2 rsls Stock And Warrants Issued During Period Value Institutional Exercise Of Warrants
StockAndWarrantsIssuedDuringPeriodValueInstitutionalExerciseOfWarrants
1571000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
6738000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3661000
us-gaap Net Income Loss
NetIncomeLoss
-6155000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-7000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
440000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
895000
rsls Adjustments To Additional Paid In Capital Stock Offering Costs
AdjustmentsToAdditionalPaidInCapitalStockOfferingCosts
91000
rsls Stock And Warrants Issued During Period Value Institutional Exercise Of Warrants
StockAndWarrantsIssuedDuringPeriodValueInstitutionalExerciseOfWarrants
7813000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
6738000
us-gaap Profit Loss
ProfitLoss
-3788000
us-gaap Profit Loss
ProfitLoss
-6155000
us-gaap Depreciation
Depreciation
12000
us-gaap Depreciation
Depreciation
75000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
22000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
429000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
33000
us-gaap Share Based Compensation
ShareBasedCompensation
137000
us-gaap Share Based Compensation
ShareBasedCompensation
440000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-169000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
145000
us-gaap Inventory Write Down
InventoryWriteDown
111000
us-gaap Inventory Write Down
InventoryWriteDown
67000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-18000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3438000
rsls Offering Cost
OfferingCost
298000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-12000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-447000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-60000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-384000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-276000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-31000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
470000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-150000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2833000
rsls Increase Decrease In Warrant Liability
IncreaseDecreaseInWarrantLiability
-177000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
11000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3429000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11723000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
43000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
33000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
24000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
12451000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12451000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-1000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-6000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3406000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
712000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4559000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3955000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1153000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4667000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
12000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:27pt;margin:0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may materially differ from these estimates. The Company reviews its estimates on an ongoing basis or as new information becomes available to ensure that these estimates appropriately reflect changes in its business.</p>
CY2024Q2 rsls Working Capital
WorkingCapital
2900000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1200000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1400000
CY2024Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
872000
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1020000
CY2024Q2 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
1219000
CY2023Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
1379000
CY2024Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1155000
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1342000
CY2024Q2 us-gaap Inventory Net
InventoryNet
3246000
CY2023Q4 us-gaap Inventory Net
InventoryNet
3741000
CY2024Q2 us-gaap Prepaid Insurance
PrepaidInsurance
149000
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
110000
CY2024Q2 rsls Prepaid Professional Services
PrepaidProfessionalServices
45000
CY2024Q2 rsls Prepaid Patent Expense Current
PrepaidPatentExpenseCurrent
7000
CY2023Q4 rsls Prepaid Patent Expense Current
PrepaidPatentExpenseCurrent
13000
CY2024Q2 us-gaap Prepaid Advertising
PrepaidAdvertising
35000
CY2023Q4 us-gaap Prepaid Advertising
PrepaidAdvertising
41000
CY2024Q2 us-gaap Prepaid Taxes
PrepaidTaxes
15000
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
47000
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
55000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
126000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
306000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
337000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
636000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
701000
CY2023Q4 rsls Accrued Legal Liabilities Current
AccruedLegalLiabilitiesCurrent
200000
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
723000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
639000
CY2024Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
58000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
61000
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
431000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
155000
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
47000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
58000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1895000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1814000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
429000
CY2024Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
429000
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
100000
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
100000
us-gaap Operating Lease Cost
OperatingLeaseCost
100000
us-gaap Operating Lease Cost
OperatingLeaseCost
200000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
202000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
250000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
113000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
111000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
103000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
151000
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
216000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
262000
us-gaap Operating Lease Payments
OperatingLeasePayments
54000
us-gaap Operating Lease Payments
OperatingLeasePayments
228000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
57000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
115000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
59000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
231000
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
15000
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
216000
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y10M24D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.069
CY2024Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
24000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10200000
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
15598392
rsls Class Of Warrant Or Right Exercised In Period
ClassOfWarrantOrRightExercisedInPeriod
10870000
rsls Class Of Warrant Or Right Cancelled In Period
ClassOfWarrantOrRightCancelledInPeriod
1968
CY2024Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4726424
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1965000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2254000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3909000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4541000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
65000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
217000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
137000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
440000
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rsls-20240630.xsd Edgar Link pending
rsls-20240630x10q.htm Edgar Link pending
rsls-20240630xex31d1.htm Edgar Link pending
rsls-20240630xex31d2.htm Edgar Link pending
rsls-20240630xex32d1.htm Edgar Link pending
rsls-20240630xex32d2.htm Edgar Link pending
Show.js Edgar Link pending
rsls-20240630_cal.xml Edgar Link unprocessable
rsls-20240630_def.xml Edgar Link unprocessable
rsls-20240630_lab.xml Edgar Link unprocessable
rsls-20240630_pre.xml Edgar Link unprocessable
rsls-20240630x10q_htm.xml Edgar Link completed
0001558370-24-012246-index-headers.html Edgar Link pending
0001558370-24-012246-index.html Edgar Link pending
0001558370-24-012246.txt Edgar Link pending
0001558370-24-012246-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable